Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Merck Sharp and Dohme Ltd. withdraws its marketing-authorisation application for Jenzyl (ridaforolimus) 30 November 2012Press releaseHuman Marvel LifeSciences Ltd withdraws its marketing-authorisation applications for Solumarv, Isomarv medium and Combimarv (human insulin) 27 November 2012Press releaseCorporate European Medicines Agency provides plan to help deal with manufacturing-related medicine shortages 26 November 2012NewsCorporateMedicines Workshop on access to clinical-trial data and transparency kicks off process towards proactive publication of data 23 November 2012Press releaseCorporate Public consultation open on phasing-in of 'black symbol' for medicines under additional monitoring 22 November 2012NewsCorporate Workshop on clinical-trial data and transparency this afternoon 22 November 2012NewsCorporate European Antibiotic Awareness Day: 18 November 2012 16 November 2012NewsCorporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2012 16 November 2012NewsHuman European Medicines Agency recommends new advice to surgeons on safer use of fibrin sealants Evicel and Quixil 16 November 2012Press releaseHumanMedicines European Medicines Agency completes review of protamine-containing medicines 16 November 2012Press releaseHumanMedicines 1 … 239 240 241 242 243 Page 243 of 384 244 245 246 247 … 384
Merck Sharp and Dohme Ltd. withdraws its marketing-authorisation application for Jenzyl (ridaforolimus) 30 November 2012Press releaseHuman
Marvel LifeSciences Ltd withdraws its marketing-authorisation applications for Solumarv, Isomarv medium and Combimarv (human insulin) 27 November 2012Press releaseCorporate
European Medicines Agency provides plan to help deal with manufacturing-related medicine shortages 26 November 2012NewsCorporateMedicines
Workshop on access to clinical-trial data and transparency kicks off process towards proactive publication of data 23 November 2012Press releaseCorporate
Public consultation open on phasing-in of 'black symbol' for medicines under additional monitoring 22 November 2012NewsCorporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2012 16 November 2012NewsHuman
European Medicines Agency recommends new advice to surgeons on safer use of fibrin sealants Evicel and Quixil 16 November 2012Press releaseHumanMedicines
European Medicines Agency completes review of protamine-containing medicines 16 November 2012Press releaseHumanMedicines